By Mulengera Reporter
In a historic public health milestone, Uganda will introduce the malaria vaccine as part of its routine immunization program in April 2025. This long-awaited intervention is set to significantly reduce severe malaria cases, hospitalizations, and deaths, particularly among children under five, the most vulnerable demographic to the disease.
Malaria remains Uganda’s leading cause of illness and death, with a staggering 12.6 million cases recorded in 2023 alone. The disease affects nearly 29% of the country’s population annually, with 32,900 new infections reported daily.
Tragically, malaria claims the lives of 16 Ugandans every day, including 10 children. These alarming statistics underscore the urgent need for an effective and sustainable solution.
The malaria vaccine, which has been tested in over 800,000 children across multiple African countries and successfully deployed in Ghana, Kenya, Malawi, Cameroon, and South Sudan, will be administered free of charge in Uganda. The rollout will prioritize districts with moderate to high malaria transmission rates.
According to the Ministry of Health, the vaccine will be given in four doses, at six, seven, eight, and eighteen months of age. Full vaccination provides optimal protection, reducing severe malaria cases by approximately 800 per day.
When combined with existing malaria prevention measures such as insecticide-treated bed nets, indoor residual spraying, and seasonal malaria chemoprevention, the vaccine is expected to save thousands of lives and significantly cut treatment costs.
Each episode of malaria treatment costs a Ugandan household an estimated UGX 15,000, a sum equivalent to the price of a meal in an average homestead. On a national scale, the economic burden of malaria is immense, draining resources from both the healthcare system and household incomes. The vaccine’s introduction is projected to alleviate this burden, boosting national productivity and improving overall public health.
The World Health Organization (WHO) and Uganda’s National Drug Authority have approved the vaccine as safe and effective. While mild side effects such as slight fever and temporary swelling at the injection site may occur, the vaccine has demonstrated a strong safety profile in countries where it has been used since 2019.
The government is calling on parents, caregivers, community leaders, and religious institutions to support the vaccination effort. “For this vaccine to be truly effective, children must receive all four doses,” emphasizes the Ministry of Health. Additionally, media and policymakers are urged to counter misinformation and ensure communities receive accurate, evidence-based information.
As Uganda takes this bold step in the fight against malaria, the introduction of the vaccine signals a new era in disease prevention, one that offers renewed hope in the battle against a disease that has plagued the country for generations. (For comments on this story, get back to us on 0705579994 [WhatsApp line], 0779411734 & 041 4674611 or email us at mulengeranews@gmail.com).
